Derma Sciences Inc (DSCI) financial statements (2020 and earlier)

Company profile

Business Address 214 CARNEGIE CENTER, SUITE 300
PRINCETON, NJ 08540
State of Incorp. PA
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:57752246
Cash and cash equivalents1619742
Short-term investments2556154
Other undisclosed cash, cash equivalents, and short-term investments16  0
Receivables8977
Inventory, net of allowances, customer advances and progress billings21131614
Inventory21131614
Prepaid expense and other current assets3
Deferred tax assets 00 
Other undisclosed current assets(15)34(0)
Total current assets:711015069
Noncurrent Assets
Property, plant and equipment4433
Long-term investments and receivables16880
Long-term investments16880
Intangible assets, net (including goodwill)23262831
Goodwill13131313
Intangible assets, net (excluding goodwill)10131517
Other noncurrent assets000
Prepaid expense and other noncurrent assets0
Total noncurrent assets:44383935
TOTAL ASSETS:11513989104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12876
Accounts payable2554
Accrued liabilities70  
Employee-related liabilities2332
Restructuring reserve1 
Deferred tax liabilities 22 
Other liabilities 211
Other undisclosed current liabilities0(1)(1)1
Total current liabilities:141298
Noncurrent Liabilities
Liabilities, other than long-term debt3322
Deferred revenue and credits 100
Deferred tax liabilities, net2222
Other liabilities1100
Other undisclosed noncurrent liabilities (1)(0)(0)
Total noncurrent liabilities:3222
Total liabilities:16141110
Stockholders' equity
Stockholders' equity attributable to parent, including:981267794
Preferred stock0000
Common stock0000
Additional paid in capital235228140132
Accumulated other comprehensive income5112
Accumulated deficit(142)(104)(64)(40)
Other undisclosed stockholders' equity attributable to parent (0)(0) 
Total stockholders' equity:981267794
TOTAL LIABILITIES AND EQUITY:11513989104

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
84848073
Cost of revenue
(Cost of Goods and Services Sold)
(52)(54)(50)(50)
Other undisclosed gross profit  02
Gross profit:33302925
Operating expenses(55)(70)(53)(40)
Operating loss:(22)(40)(24)(14)
Nonoperating income (expense)(1)000
Investment income, nonoperating000 
Foreign currency transaction gain (loss), before tax0(0)  
Other nonoperating income   0
Loss from continuing operations before income taxes:(23)(40)(24)(14)
Income tax expense (benefit)20(0)2
Net loss:(20)(40)(24)(12)
Net loss attributable to noncontrolling interest(18)   
Net loss available to common stockholders, diluted:(38)(40)(24)(12)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(20)(40)(24)(12)
Other comprehensive income (loss)4(0)(1) 
Comprehensive loss:(16)(40)(24)(12)
Comprehensive loss, net of tax, attributable to noncontrolling interest(18)   
Other undisclosed comprehensive income, net of tax, attributable to parent   0
Comprehensive loss, net of tax, attributable to parent:(34)(40)(24)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: